Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Sports Medicine
Published in: Sports Medicine 1/2018

01-01-2018 | Review Article

Physical Activity in Preventing Alzheimer’s Disease and Cognitive Decline: A Narrative Review

Authors: Stefano Brini, Hamid R. Sohrabi, Jeremiah J. Peiffer, Mira Karrasch, Heikki Hämäläinen, Ralph N. Martins, Timothy J. Fairchild

Published in: Sports Medicine | Issue 1/2018

Login to get access

Abstract

A large body of epidemiological and experimental data exploring the relationship between physical activity (PA) and Alzheimer’s disease (AD) are now available. Despite observational evidence supporting a role for PA in delaying the onset of AD, randomised controlled trials have reported mixed findings, likely due to the heterogeneity in study cohorts, outcome measures, and the adopted PA intervention. The primary objective of this narrative review is to evaluate the extant evidence on the relationship between PA, cognitive decline and AD in older populations. The interaction between PA and the putative mechanisms underlying AD progression, including genetic factors and amyloid-β levels will be explored. In this context, particular attention will be given to studies assessing PA in the early clinical and preclinical, asymptomatic stages of AD. Based on current evidence, clinical considerations for implementation of exercise-based interventions are discussed, along with limitations of previous research and directions for future studies.
Literature
1.
Wimo A, Guerchet M, Ali GC, Wu YT, Prina AM, Winblad B, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017;13(1):1–7.PubMedPubMedCentralCrossRef
2.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75.PubMedCrossRef
3.
Wortmann M. Dementia: a global health priority-highlights from an ADI and World Health Organization report. Alzheimers Res Ther. 2012;4(5):40.PubMedPubMedCentral
4.
Graham WV, Bonito-Oliva A, Sakmar TP. Update on Alzheimer’s disease therapy and prevention strategies. Annu Rev Med. 2017;68:413–30.PubMedCrossRef
5.
6.
7.
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–9.PubMedPubMedCentralCrossRef
8.
Epelbaum S, Genthon R, Cavedo E, Habert MO, Lamari F, Gagliardi G, et al. Preclinical Alzheimer’s disease: a systematic review of the cohorts underlying the concept. Alzheimers Dement. 2017;13(4):454–67.PubMedCrossRef
9.
Jessen F, Wolfsgruber S, Wiese B, Bickel H, Mösch E, Kaduszkiewicz H, et al. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement. 2014;10(1):76–83.PubMedCrossRef
10.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9.PubMedPubMedCentralCrossRef
11.
Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130(6):439–51.PubMedCrossRef
12.
13.
Haan MN, Wallace R. Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health. 2004;25:1–24.PubMedCrossRef
14.
Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, Chételat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement. 2014;10(6):844–52.PubMedPubMedCentralCrossRef
15.
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):280–92.PubMedPubMedCentralCrossRef
16.
17.
18.
Sala Frigerio C, De Strooper B. Alzheimer’s disease mechanisms and emerging roads to novel therapeutics. Annu Rev Neurosci. 2016;39:57–79.PubMedCrossRef
19.
Karran E, Hardy J. A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. Ann Neurol. 2014;76(2):185–205.PubMedPubMedCentralCrossRef
20.
Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry. 2000;15(11):983–91.PubMedCrossRef
21.
Larrabee GJ, Crook TH. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr. 1994;6(01):95–104.PubMedCrossRef
22.
Crumley JJ, Stetler CA, Horhota M. Examining the relationship between subjective and objective memory performance in older adults: a meta-analysis. Psychol Aging. 2014;29(2):250–63.PubMedCrossRef
23.
van der Flier WM, van Buchem MA, Weverling-Rijnsburger AWE, Mutsaers ER, Bollen ELEM, Admiraal-Behloul F, et al. Memory complaints in patients with normal cognition are associated with smaller hippocampal volumes. J Neurol. 2004;251(6):671–5.PubMedCrossRef
24.
Mendonça MD, Alves L, Bugalho P. From subjective cognitive complaints to dementia who is at risk? A systematic review. Am J Alzheimers Dis Other Demen. 2015;31(2):105–14.CrossRef
25.
Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA. 2008;300(9):1027–37.PubMedCrossRef
26.
Shah T, Verdile G, Sohrabi H, Campbell A, Putland E, Cheetham C, et al. A combination of physical activity and computerized brain training improves verbal memory and increases cerebral glucose metabolism in the elderly. Transl Psychiatry. 2014;4(12):e487.PubMedPubMedCentralCrossRef
27.
Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–63.PubMedCrossRef
28.
Öhman H, Savikko N, Strandberg TE, Pitkälä KH. Effect of physical exercise on cognitive performance in older adults with mild cognitive impairment or dementia: a systematic review. Dement Geriatr Cogn Disord. 2014;38(5–6):347–65.PubMedCrossRef
29.
Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S. Exercise programs for people with dementia. Cochrane Libr. 2015.doi:10.1002/14651858
30.
Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003;163(13):1524–8.PubMedCrossRef
31.
Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62(10):1556–60.PubMedCrossRef
32.
Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol. 2009;66(3):324–8.PubMedPubMedCentralCrossRef
33.
Beydoun MA, Beydoun H, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev. 2008;9(3):204–18.PubMedPubMedCentralCrossRef
34.
Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry. 2010;67(6):505–12.PubMedCrossRef
35.
36.
Fontbonne A, Berr C, Ducimetière P, Alpérovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects results of the epidemiology of vascular aging study. Diabetes care. 2001;24(2):366–70.PubMedCrossRef
37.
Munshi M, Grande L, Hayes M, Ayres D, Suhl E, Capelson R, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care. 2006;29(8):1794–9.PubMedPubMedCentralCrossRef
38.
Grodstein F, Chen J, Wilson RS, Manson JE. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care. 2001;24(6):1060–5.PubMedCrossRef
39.
Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med. 2004;164(12):1327–33.PubMedCrossRef
40.
Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care. 2006;29(2):345–51.PubMedCrossRef
41.
Cukierman T, Gerstein H, Williamson J. Cognitive decline and dementia in diabetes: systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460–9.PubMedCrossRef
42.
Kalil GZ, Haynes WG. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res. 2012;35(1):4–16.PubMedCrossRef
43.
Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, Gray LJ, et al. Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia. 2012;55(1):2895–905.PubMedCrossRef
44.
45.
Goldberg I, Auriel E, Russell D, Korczyn A. Microembolism, silent brain infarcts and dementia. J Neurol Sci. 2012;322(1):250–3.PubMedCrossRef
46.
Thorp AA, Owen N, Neuhaus M, Dunstan DW. Sedentary behaviors and subsequent health outcomes in adults: a systematic review of longitudinal studies, 1996–2011. Am J Prev Med. 2011;41(2):207–15.PubMedCrossRef
47.
Grøntved A, Hu FB. Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis. JAMA. 2011;305(23):2448–55.PubMedPubMedCentralCrossRef
48.
Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med. 2004;164(3):249–58.PubMedCrossRef
49.
50.
Mayer-Davis EJ, Costacou T. Obesity and sedentary lifestyle: modifiable risk factors for prevention of type 2 diabetes. Curr Diab Rep. 2001;1(2):170–6.PubMedCrossRef
51.
Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788–94.PubMedCrossRef
52.
Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JP, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2016;13(4):406–18.PubMedCrossRef
53.
Etgen T, Sander D, Huntgeburth U, Poppert H, Förstl H, Bickel H. Physical activity and incident cognitive impairment in elderly persons: the INVADE study. Arch Intern Med. 2010;170(2):186–93.PubMedCrossRef
54.
Middleton LE, Barnes DE, Lui LY, Yaffe K. Physical activity over the life course and its association with cognitive performance and impairment in old age. J Am Geriatr Soc. 2010;58(7):1322–6.PubMedPubMedCentralCrossRef
55.
Sofi F, Valecchi D, Bacci D, Abbate R, Gensini G, Casini A, et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med. 2011;269(1):107–17.PubMedCrossRef
56.
Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58(3):498–504.PubMedCrossRef
57.
Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med. 2009;39(01):3–11.PubMedCrossRef
58.
Buchman A, Boyle P, Yu L, Shah R, Wilson R, Bennett D. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012;78(17):1323–9.PubMedPubMedCentralCrossRef
59.
Focht BC, Sanders WM, Brubaker PH, Rejeski WJ. Initial validation of the CSA activity monitor during rehabilitative exercise among older adults with chronic disease. J Aging Phys Activ. 2003;11(3):293–304.CrossRef
60.
Boon H, Frisard M, Brown C, Jazwinski SM, Delany J, Ravussin E. Validation of accelerometers to assess physical activity in elderly subjects. Obes Res. 2003;11:8.
61.
Baranowski T. Validity and reliability of self report measures of physical-activity: an information-processing perspective. Res Q Exerc Sport. 1988;59(4):314–27.CrossRef
62.
Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004;3(6):343–53.PubMedCrossRef
63.
Sturman MT, Morris MC, de Leon CFM, Bienias JL, Wilson RS, Evans DA. Physical activity, cognitive activity, and cognitive decline in a biracial community population. Arch Neurol. 2005;62(11):1750–4.PubMedCrossRef
64.
Wang H-X, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol. 2002;155(12):1081–7.PubMedCrossRef
65.
Niti M, Yap K-B, Kua E-H, Tan C-H, Ng T-P. Physical, social and productive leisure activities, cognitive decline and interaction with APOE-ε4 genotype in Chinese older adults. Int Psychogeriatr. 2008;20(2):237–51.PubMedCrossRef
66.
Podewils LJ, Guallar E, Kuller LH, Fried LP, Lopez OL, Carlson M, et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol. 2005;161(7):639–51.PubMedCrossRef
67.
Van de Winckel A, Feys H, De Weerdt W, Dom R. Cognitive and behavioural effects of music-based exercises in patients with dementia. Clin Rehabil. 2004;18(3):253–60.PubMedCrossRef
68.
Arcoverde C, Deslandes A, Moraes H, Almeida C, Araujo NBd, Vasques PE, et al. Treadmill training as an augmentation treatment for Alzheimer? s disease: a pilot randomized controlled study. Arq Neuropsiquiatr. 2014;72(3):190–6.PubMedCrossRef
69.
Venturelli M, Scarsini R, Schena F. Six-month walking program changes cognitive and ADL performance in patients with Alzheimer. Am J Alzheimers Dis Other Demen. 2011;26(5):381–8.PubMedCrossRef
70.
van Belle G, Uhlmann RF, Hughes JP, Larson EB. Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type. J Clin Epidemiol. 1990;43(6):589–95.PubMedCrossRef
71.
Eggermont L, Swaab D, Hol E, Scherder E. Walking the line: a randomised trial on the effects of a short term walking programme on cognition in dementia. J Neurol Neurosurg Psychiatry. 2009;80(7):802–4.PubMedCrossRef
72.
Bossers WJ, van der Woude LH, Boersma F, Hortobágyi T, Scherder EJ, van Heuvelen MJ. A 9-week aerobic and strength training program improves cognitive and motor function in patients with dementia: a randomized, controlled trial. Am J Geriatr Psychiatry. 2015;23(11):1106–16.PubMedCrossRef
73.
Groot C, Hooghiemstra A, Raijmakers P, van Berckel B, Scheltens P, Scherder E, et al. The effect of physical activity on cognitive function in patients with dementia: a meta-analysis of randomized control trials. Ageing Res Rev. 2016;25:13–23.PubMedCrossRef
74.
Steinberg M, Leoutsakos JMS, Podewils LJ, Lyketsos C. Evaluation of a home-based exercise program in the treatment of Alzheimer’s disease: the Maximizing Independence in Dementia (MIND) study. Int J Geriatr Psychiatry. 2009;24(7):680–5.PubMedPubMedCentralCrossRef
75.
Miu D, Szeto S, Mak Y. A randomised controlled trial on the effect of exercise on physical, cognitive and affective function in dementia subjects. Asian J Gerontol Geriatr. 2008;3:8–16.
76.
Kemoun G, Thibaud M, Roumagne N, Carette P, Albinet C, Toussaint L, et al. Effects of a physical training programme on cognitive function and walking efficiency in elderly persons with dementia. Dement Geriatr Cogn Disord. 2010;29(2):109–14.PubMedCrossRef
77.
Kwak Y-S, Um S-Y, Son T-G, Kim D-J. Effect of regular exercise on senile dementia patients. Int J Sports Med. 2008;29(6):471–4.PubMedCrossRef
78.
Rockwood K, Middleton L. Physical activity and the maintenance of cognitive function. Alzheimers Dement. 2007;3(2):S38–44.PubMedCrossRef
79.
Semba RD, Moghekar AR, Hu J, Sun K, Turner R, Ferrucci L, et al. Klotho in the cerebrospinal fluid of adults with and without Alzheimer’s disease. Neurosci Lett. 2014;558:37–40.PubMedCrossRef
80.
Papassotiropoulos A, Stephan DA, Huentelman MJ, Hoerndli FJ, Craig DW, Pearson JV, et al. Common Kibra alleles are associated with human memory performance. Science. 2006;314(5798):475–8.PubMedCrossRef
81.
Milnik A, Heck A, Vogler C, Heinze HJ, de Quervain DJF, Papassotiropoulos A. Association of KIBRA with episodic and working memory: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2012;159(8):958–69.CrossRef
82.
Shardell M, Semba RD, Rosano C, Kalyani RR, Bandinelli S, Chia CW, et al. Plasma klotho and cognitive decline in older adults: findings from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2015;71(5):677–82.PubMedPubMedCentralCrossRef
83.
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA. 1997;278(16):1349–56.PubMedCrossRef
84.
Yu J-T, Tan L, Hardy J. Apolipoprotein E in Alzheimer’s disease: an update. Annu Rev Neurosci. 2014;37:79–100.PubMedCrossRef
85.
86.
Purnell C, Gao S, Callahan CM, Hendrie HC. Cardiovascular risk factors and incident Alzheimer disease: A systematic review of the literature. Alzheimer Dis Assoc Disord. 2009;23(1):1–10.PubMedPubMedCentralCrossRef
87.
Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141(2):137–47.PubMedCrossRef
88.
Grimmer T, Tholen S, Yousefi BH, Alexopoulos P, Förschler A, Förstl H, et al. Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer’s disease. Biol Psychiatry. 2010;68(10):879–84.PubMedPubMedCentralCrossRef
89.
Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JWR, Van Kamp GJ, et al. Memory complaints and APOE-ε4 accelerate cognitive decline in cognitively normal elderly. Neurology. 2001;57(12):2217–22.PubMedCrossRef
90.
Mosconi L, De Santi S, Brys M, Tsui WH, Pirraglia E, Glodzik-Sobanska L, et al. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry. 2008;63(6):609–18.PubMedCrossRef
91.
92.
Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem. 2002;9(5):224–37.PubMedPubMedCentralCrossRef
93.
Fumagalli F, Racagni G, Riva M. The expanding role of BDNF: a therapeutic target for Alzheimer’s disease? Pharmacogenom J. 2006;6(1):8–15.CrossRef
94.
Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron. 1991;7(5):695–702.PubMedCrossRef
95.
Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y, et al. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry. 2008;69(7):1104–11.PubMedCrossRef
96.
Holsinger RD, Schnarr J, Henry P, Castelo VT, Fahnestock M. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer’s disease. Brain Res Mol Brain Res. 2000;76(2):347–54.PubMedCrossRef
97.
Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H. Serum BDNF, TNF-α and IL-1β levels in dementia patients. Eur Arch Psychiatry Clin Neurosci. 2006;256(7):402–6.PubMedCrossRef
98.
Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease. J Neurochem. 2005;93(6):1412–21.PubMedCrossRef
99.
Shimada H, Makizako H, Yoshida D, Tsutsumimoto K, Anan Y, Uemura K, et al. A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly. Front Aging Neurosci. 2014;6:69.PubMedPubMedCentralCrossRef
100.
Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res. 1996;36(2):280–6.PubMedCrossRef
101.
Small BJ, Rosnick CB, Fratiglioni L, Bäckman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging. 2004;19(4):592–600.PubMedCrossRef
102.
Schuit AJ, Feskens EJ, Launer LJ, Kromhout DAAN. Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc. 2001;33(5):772–7.PubMedCrossRef
103.
Etnier JL, Caselli RJ, Reiman EM, Alexander GE, Sibley BA, Tessier D, et al. Cognitive performance in older women relative to ApoE-e4 genotype and aerobic fitness. Med Sci Sports Exerc. 2007;39(1):199–207.PubMedCrossRef
104.
Smith JC, Nielson KA, Woodard JL, Seidenberg M, Rao SM. Physical activity and brain function in older adults at increased risk for Alzheimer’s disease. Brain Sci. 2013;3(1):54–83.PubMedPubMedCentralCrossRef
105.
Rovio S, Kåreholt I, Helkala E-L, Viitanen M, Winblad B, Tuomilehto J, et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol. 2005;4(11):705–11.PubMedCrossRef
106.
Correia PR, Scorza FA, da Silva SG, Pansani A, Toscano-Silva M, de Almeida AC, et al. Increased basal plasma brain-derived neurotrophic factor levels in sprint runners. Neurosci Bull. 2011;27(5):325–9.PubMedPubMedCentralCrossRef
107.
Zoladz J, Pilc A, Majerczak J, Grandys M, Zapart-Bukowska J, Duda K. Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. J Physiol Pharmacol. 2008;59(Suppl 7):119–32.PubMed
108.
Chan KL, Tong KY, Yip SP. Relationship of serum brain-derived neurotrophic factor (BDNF) and health-related lifestyle in healthy human subjects. Neurosci Lett. 2008;447(2):124–8.PubMedCrossRef
109.
Jung SH, Kim J, Davis JM, Blair SN, Cho H-C. Association among basal serum BDNF, cardiorespiratory fitness and cardiovascular disease risk factors in untrained healthy Korean men. Eur J Appl Physiol. 2011;111(2):303–11.PubMedCrossRef
110.
Nofuji Y, Suwa M, Moriyama Y, Nakano H, Ichimiya A, Nishichi R, et al. Decreased serum brain-derived neurotrophic factor in trained men. Neurosci Lett. 2008;437(1):29–32.PubMedCrossRef
111.
Winker R, Lukas I, Perkmann T, Haslacher H, Ponocny E, Lehrner J, et al. Cognitive function in elderly marathon runners: cross-sectional data from the marathon trial (APSOEM). Wien Klin Wochenschr. 2010;122(23–24):704–16.PubMedCrossRef
112.
Huang T, Larsen K, Ried-Larsen M, Møller N, Andersen LB. The effects of physical activity and exercise on brain-derived neurotrophic factor in healthy humans: a review. Scand J Med Sci Sports. 2014;24(1):1–10.PubMedCrossRef
113.
Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N, et al. Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol. 2008;197(2):429–35.PubMedCrossRef
114.
Pluchino N, Cubeddu A, Begliuomini S, Merlini S, Giannini A, Bucci F, et al. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum Reprod. 2009;24(9):2303–9.PubMedCrossRef
115.
Griffin ÉW, Mullally S, Foley C, Warmington SA, O’Mara SM, Kelly ÁM. Aerobic exercise improves hippocampal function and increases BDNF in the serum of young adult males. Physiol Behav. 2011;104(5):934–41.PubMedCrossRef
116.
Ruscheweyh R, Willemer C, Krüger K, Duning T, Warnecke T, Sommer J, et al. Physical activity and memory functions: an interventional study. Neurobiol Aging. 2011;32(7):1304–19.PubMedCrossRef
117.
Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010;67(1):71–9.PubMedPubMedCentralCrossRef
118.
Ferris LT, Williams JS, Shen C-L. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med Sci Sports Exerc. 2007;39(4):728–34.PubMedCrossRef
119.
Goekint M, Heyman E, Roelands B, Njemini R, Bautmans I, Mets T, et al. No influence of noradrenaline manipulation on acute exercise-induced increase of brain-derived neurotrophic factor. Med Sci Sports Exerc. 2008;40(11):1990–6.PubMedCrossRef
120.
Gustafsson G, Lira CM, Johansson J, Wisén A, Wohlfart B, Ekman R, et al. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatry Res. 2009;169(3):244–8.PubMedCrossRef
121.
Vega SR, Strüder HK, Wahrmann BV, Schmidt A, Bloch W, Hollmann W. Acute BDNF and cortisol response to low intensity exercise and following ramp incremental exercise to exhaustion in humans. Brain Res. 2006;1121(1):59–65.CrossRef
122.
Vega SR, Abel T, Lindschulten R, Hollmann W, Bloch W, Strüder H. Impact of exercise on neuroplasticity-related proteins in spinal cord injured humans. Neurosci. 2008;153(4):1064–70.CrossRef
123.
Tang SW, Chu E, Hui T, Helmeste D, Law C. Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects. Neurosci Lett. 2008;431(1):62–5.PubMedCrossRef
124.
Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. 2009;94(10):1062–9.PubMedCrossRef
125.
Knaepen K, Goekint M, Heyman EM, Meeusen R. Neuroplasticity: exercise-induced response of peripheral brain-derived neurotrophic factor. Sports Med. 2010;40(9):765–801.PubMedCrossRef
126.
Coelho F, Pereira D, Lustosa L, Silva J, Dias J, Dias R, et al. Physical therapy intervention (PTI) increases plasma brain-derived neurotrophic factor (BDNF) levels in non-frail and pre-frail elderly women. Arch Gerontol Geriatr. 2012;54(3):415–20.PubMedCrossRef
127.
Yarrow JF, White LJ, McCoy SC, Borst SE. Training augments resistance exercise induced elevation of circulating brain derived neurotrophic factor (BDNF). Neurosci Lett. 2010;479(2):161–5.PubMedCrossRef
128.
Correia PR, Pansani A, Machado F, Andrade M, Silva AC, Scorza FA, et al. Acute strength exercise and the involvement of small or large muscle mass on plasma brain-derived neurotrophic factor levels. Clinics. 2010;65(11):1123–6.PubMedPubMedCentralCrossRef
129.
Schiffer T, Schulte S, Hollmann W, Bloch W, Strüder H. Effects of strength and endurance training on brain-derived neurotrophic factor and insulin-like growth factor 1 in humans. Horm Metab Res. 2009;41(03):250–4.PubMedCrossRef
130.
Levinger I, Goodman C, Matthews V, Hare DL, Jerums G, Garnham A, et al. BDNF, metabolic risk factors, and resistance training in middle-aged individuals. Med Sci Sports Exerc. 2008;40(3):535–41.PubMedCrossRef
131.
Katoh-Semba R, Wakako R, Komori T, Shigemi H, Miyazaki N, Ito H, et al. Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls. Int J Dev Neurosci. 2007;25(6):367–72.PubMedCrossRef
132.
Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357–67.PubMedCrossRef
133.
Vellas B, Aisen PS, Sampaio C, Carrillo M, Scheltens P, Scherrer B, et al. Prevention trials in Alzheimer’s disease: an EU-US task force report. Prog Neurobiol. 2011;95(4):594–600.PubMedCrossRef
134.
Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, et al. Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s disease neuroimaging initiative (ADNI). Alzheimers Dement. 2005;1(1):55–66.PubMedPubMedCentralCrossRef
135.
Patwardhan MB, McCrory DC, Matchar DB, Samsa GP, Rutschmann OT. Alzheimer disease: operating characteristics of PET—a meta-analysis. Radiol. 2004;231(1):73–80.CrossRef
136.
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306–19.PubMedCrossRef
137.
Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging. 2010;31(8):1275–83.PubMedCrossRef
138.
Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2013;40(1):104–14.PubMedCrossRef
139.
Rowe CC, Bourgeat P, Ellis KA, Brown B, Lim YY, Mulligan R, et al. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Ann Neurol. 2013;74(6):905–13.PubMedCrossRef
140.
Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ. Pre-clinical detection of Alzheimer’s disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis. 2010;20(3):843–54.PubMedPubMedCentralCrossRef
141.
Liang KY, Mintun MA, Fagan AM, Goate AM, Bugg JM, Holtzman DM, et al. Exercise and Alzheimer’s disease biomarkers in cognitively normal older adults. Ann Neurol. 2010;68(3):311–8.PubMedPubMedCentralCrossRef
142.
Brown B, Peiffer J, Taddei K, Lui J, Laws S, Gupta VB, et al. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle study of ageing. Mol Psychiatry. 2013;18(8):875–81.PubMedCrossRef
143.
Head D, Bugg JM, Goate AM, Fagan AM, Mintun MA, Benzinger T, et al. Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch Neurol. 2012;69(5):636–43.PubMedPubMedCentralCrossRef
144.
Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Update on hypothetical model of Alzheimer’s disease biomarkers. Lancet Neurol. 2013;12(2):207–16.PubMedPubMedCentralCrossRef
145.
Ibanez V, Pietrini P, Alexander G, Furey M, Teichberg D, Rajapakse J, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer’s disease. Neurology. 1998;50(6):1585–93.PubMedCrossRef
146.
Deeny SP, Winchester J, Nichol K, Roth SM, Wu JC, Dick M, et al. Cardiovascular fitness is associated with altered cortical glucose metabolism during working memory in ɛ4 carriers. Alzheimers Dement. 2012;8(4):352–6.PubMedPubMedCentralCrossRef
147.
Rolland Y, van Kan GA, Vellas B. Physical activity and Alzheimer’s disease: from prevention to therapeutic perspectives. J Am Med Dir Assoc. 2008;9(6):390–405.PubMedCrossRef
148.
Warren JM, Ekelund U, Besson H, Mezzani A, Geladas N, Vanhees L. Assessment of physical activity—a review of methodologies with reference to epidemiological research: a report of the exercise physiology section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(2):127–39.PubMedCrossRef
149.
150.
Aadahl M, Kjær M, Jørgensen T. Perceived exertion of physical activity: negative association with self-rated fitness. Scand J Public Health. 2007;35(4):403–9.PubMedCrossRef
151.
Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002;156(5):445–53.PubMedCrossRef
152.
Prakash RS, Voss MW, Erickson KI, Kramer AF. Physical activity and cognitive vitality. Annu Rev Psychol. 2015;66:769–97.PubMedCrossRef
153.
van Uffelen JG, Paw MJCA, Hopman-Rock M, van Mechelen W. The effects of exercise on cognition in older adults with and without cognitive decline: a systematic review. Clin J Sport Med. 2008;18(6):486–500.PubMedCrossRef
154.
Prince SA, Adamo KB, Hamel ME, Hardt J, Gorber SC, Tremblay M. A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act. 2008;5(1):56.PubMedPubMedCentralCrossRef
155.
Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S, et al. Exercise program for nursing home residents with Alzheimer’s disease: a 1-year randomized, controlled trial. J Am Geriatr Soc. 2007;55(2):158–65.PubMedCrossRef
156.
Larson EB. Physical activity for older adults at risk for Alzheimer disease. JAMA. 2008;300(9):1077–9.PubMedCrossRef
157.
Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G. Endpoints for trials in Alzheimer’s disease: a European task force consensus. Lancet Neurol. 2008;7(5):436–50.PubMedCrossRef
158.
Vellas B, Andrieu S, Sampaio C, Wilcock G. Disease-modifying trials in Alzheimer’s disease: a European task force consensus. Lancet Neurol. 2007;6(1):56–62.PubMedCrossRef
159.
McGlone J, Gupta S, Humphrey D, Oppenheimer S, Mirsen T, Evans DR. Screening for early dementia using memory complaints from patients and relatives. Arch Neurol. 1990;47(11):1189–93.PubMedCrossRef
160.
Tierney MC, Szalai JP, Snow WG, Fisher RH. The prediction of Alzheimer disease: the role of patient and informant perceptions of cognitive deficits. Arch Neurol. 1996;53(5):423–7.PubMedCrossRef
Metadata
Title
Physical Activity in Preventing Alzheimer’s Disease and Cognitive Decline: A Narrative Review
Authors
Stefano Brini
Hamid R. Sohrabi
Jeremiah J. Peiffer
Mira Karrasch
Heikki Hämäläinen
Ralph N. Martins
Timothy J. Fairchild
Publication date
01-01-2018
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 1/2018
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-017-0787-y

Other articles of this Issue 1/2018

Sports Medicine 1/2018 Go to the issue

Review Article

What’s Next in Complex Networks? Capturing the Concept of Attacking Play in Invasive Team Sports

Correction

Correction to: Effectiveness of Exercise Interventions to Improve Postural Control in Older Adults: A Systematic Review and Meta-Analyses of Centre of Pressure Measurements

Systematic Review

Effects of Rest Interval Duration in Resistance Training on Measures of Muscular Strength: A Systematic Review

Systematic Review

The Effects of Hyperoxia on Sea-Level Exercise Performance, Training, and Recovery: A Meta-Analysis

Systematic Review

The Activity Demands and Physiological Responses Encountered During Basketball Match-Play: A Systematic Review

Original Research Article

Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys